Please login to the form below

Not currently logged in
Email:
Password:

Digital intelligence blog

Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools

UK drug regulator the MHRA joins Twitter

Regulator's press office begins using the social network

Medicines regulator MHRA Twitter

UK drug regulator the MHRA has started using Twitter to issue official communications such as press releases and statements.

Its new @MHRAGovUKPress account began tweeting yesterday and marks a new level of social media engagement for the regulator.

The account is being run by the communications team, which says it will provide “another way to find out the latest news from the MHRA in real time”.

However, announcing the launch of the new account the MHRA noted that that “specific enquiries about press releases” should continue to go through its press office.

To date the regulator's use of Twitter has focused on the Herbal Remedy Safety account it launched over the summer and the new press office account has already been building on this.

Its first two tweets warned of the importance of only using herbal remedies that are registered and also highlighted the withdrawal from the market of a herbal product.

The regulator is also considering allowing adverse events to be reported through social media channels like Facebook and Twitter.

Mick Foy, group manager for vigilance and risk management of medicines at the MHRA, told GP in September: “Applications for smartphones, improved web reporting forms and the use of social media such as Twitter and Facebook are being carefully considered as potential routes for reporting.”

Earlier this year the ABPI's Pharmacovigilance Expert Network produced Guidance notes on the management of adverse events and product complaints from pharmaceutical company sponsored websites.

It said blogs, tweets and on-line medical communities could be “alternative sources of potentially important safety information”, and compliment traditional methods if accessed and analysed appropriately.

The MHRA joins a number of other regulators on the Twitter. The US Food and Drug Administration (FDA) has ten accounts (the Eye On The FDA blog has a handy overview) and the European Medicines Agency has a single news-focused account.

13th December 2011

From: Marketing

Share

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Nucleus Global

Nucleus Global is the largest specialist medical communications network in the world. Globally, we have over 800 experts delivering world-class...

Latest intelligence

Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...
The heavy toll of COVID-19 on cancer patients
We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of...

Infographics